STAAR Surgical Company (STAA)

Return on total capital

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 28,097 18,656 26,066 34,489 43,802 50,221 44,353 37,982 33,339 30,033 27,078 15,374 6,769 5,034 3,486 9,152 11,852 10,697 8,946 7,361
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 385,954 378,595 357,617 338,924 336,112 323,142 302,317 276,317 261,568 249,108 234,622 214,176 197,222 186,392 174,674 164,967 159,884 149,340 144,335 137,338
Return on total capital 7.28% 4.93% 7.29% 10.18% 13.03% 15.54% 14.67% 13.75% 12.75% 12.06% 11.54% 7.18% 3.43% 2.70% 2.00% 5.55% 7.41% 7.16% 6.20% 5.36%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $28,097K ÷ ($—K + $385,954K)
= 7.28%

STAAR Surgical Company's return on total capital has shown fluctuations over the past few quarters. The return on total capital ranged from a low of 2.00% in June 2020 to a high of 15.54% in September 2022. The trend indicates that the company's ability to generate profits relative to its total capital employed has varied over time.

The return on total capital stood at 7.28% as of December 31, 2023, which reflects a moderate return compared to historical data. This may suggest that the company needs to focus on efficiently utilizing its capital to increase profitability.

Overall, a consistent and steady increase in return on total capital would indicate that STAAR Surgical Company is effectively utilizing its total capital to generate returns for its investors. Monitoring this ratio over time can provide valuable insight into the company's financial performance and efficiency in deploying capital resources.


Peer comparison

Dec 31, 2023

Company name
Symbol
Return on total capital
STAAR Surgical Company
STAA
7.28%
National Vision Holdings Inc
EYE
-3.70%
The Cooper Companies Inc.
COO
4.99%